408 related articles for article (PubMed ID: 32038101)
1. Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children.
Zhu Q; Tang Y; Guo L; Tighe S; Zhou Y; Zhang X; Zhang J; Zhu Y; Hu M
Int J Med Sci; 2020; 17(2):176-181. PubMed ID: 32038101
[No Abstract] [Full Text] [Related]
2. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
3. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
[TBL] [Abstract][Full Text] [Related]
4. Topical Atropine in the Control of Myopia.
Tan D; Tay SA; Loh KL; Chia A
Asia Pac J Ophthalmol (Phila); 2016; 5(6):424-428. PubMed ID: 27898446
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
[TBL] [Abstract][Full Text] [Related]
6. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
7. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.
Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Ji N; Lyu Y
Br J Ophthalmol; 2020 Nov; 104(11):1535-1541. PubMed ID: 32086237
[TBL] [Abstract][Full Text] [Related]
9. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.
Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK
Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137
[TBL] [Abstract][Full Text] [Related]
10. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.
Chia A; Chua WH; Wen L; Fong A; Goon YY; Tan D
Am J Ophthalmol; 2014 Feb; 157(2):451-457.e1. PubMed ID: 24315293
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for progressive myopia in the atropine therapy for myopia study.
Loh KL; Lu Q; Tan D; Chia A
Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
[TBL] [Abstract][Full Text] [Related]
12. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
Chia A; Lu QS; Tan D
Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
[TBL] [Abstract][Full Text] [Related]
13. Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study.
Chia A; Ngo C; Choudry N; Yamakawa Y; Tan D
Asia Pac J Ophthalmol (Phila); 2023 Jul-Aug 01; 12(4):370-376. PubMed ID: 37523428
[TBL] [Abstract][Full Text] [Related]
14. Prevention of myopia onset with 0.025% atropine in premyopic children.
Fang PC; Chung MY; Yu HJ; Wu PC
J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
[TBL] [Abstract][Full Text] [Related]
15. Atropine treatment for myopia.
Brown SM
Ophthalmology; 2009 Oct; 116(10):2040; author reply 2040-1. PubMed ID: 19800530
[No Abstract] [Full Text] [Related]
16. Therapeutic effect of atropine 1% in children with low myopia.
Yi S; Huang Y; Yu SZ; Chen XJ; Yi H; Zeng XL
J AAPOS; 2015 Oct; 19(5):426-9. PubMed ID: 26228967
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.
Long H; Shi MH; Li X
J Fr Ophtalmol; 2023 Oct; 46(8):929-940. PubMed ID: 37147148
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Changes in Refraction and Biometry of Atropine- and Placebo-Treated Eyes.
Kumaran A; Htoon HM; Tan D; Chia A
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5650-5. PubMed ID: 26313301
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
[TBL] [Abstract][Full Text] [Related]
20. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
Yam JC; Zhang XJ; Zhang Y; Yip BHK; Tang F; Wong ES; Bui CHT; Kam KW; Ng MPH; Ko ST; Yip WWK; Young AL; Tham CC; Chen LJ; Pang CP
JAMA; 2023 Feb; 329(6):472-481. PubMed ID: 36786791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
